Login/Sign Up
₹5740*
MRP ₹7000
18% off
₹5950*
MRP ₹7000
15% CB
₹1050 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Online payment accepted
Provide Delivery Location
Whats That
Country of origin
Alcohol
Caution
Limit or avoid consumption of alcohol as it may worsen your condition.
Pregnancy
Unsafe
Bizisa Injection 1's is not recommended for use in pregnancy as it may harm your foetus. Hence, if you are pregnant or planning pregnancy, inform your doctor before receiving Bizisa Injection 1's. Use reliable methods of birth control while on treatment with Bizisa Injection 1's.
Breast Feeding
Caution
If you are a nursing mother, inform your doctor before receiving Bizisa Injection 1's. You should not breastfeed while on treatment with Bizisa Injection 1's.
Driving
Not applicable
-
Liver
Caution
If you have a pre-existing or a history of liver disease, inform your doctor before receiving Bizisa Injection 1's. A dose adjustment of this medicine or a suitable alternative may be advised based on your condition. Bizisa Injection 1's is not recommended for use in patients with severe liver disease.
Kidney
Caution
If you have a pre-existing or a history of kidney disease, inform your doctor before receiving Bizisa Injection 1's. A dose adjustment of this medicine or a suitable alternative may be advised based on your condition. This medicine should be avoided for patients with CrCl <40 ml/min.
Children
Unsafe
Bizisa Injection 1's is not recommended for use in children as the safety and efficacy is not established.
Product Substitutes
About Bizisa Injection 1's
Bizisa Injection 1's belongs to a class of anti-cancer medicines used in the treatment of Leukemia. Leukemia, also known as blood cancer, is a cancer of blood cells or blood-forming tissues. This medicine is used in the treatment of Chronic lymphocytic leukemia (CLL) and indolent B-cell non-Hodgkin’s leukemia (NHL) that has progressed during six months of treatment with rituximab or rituximab-containing treatment.
Bizisa Injection 1's contains Bendamustine, which belongs to the alkylating agents class. It works by inhibiting the DNA and RNA transcription that is essential for protein synthesis.
Bizisa Injection 1's may cause certain side effects, such as nausea, vomiting, diarrhea, stomach pain, anorexia, decreased weight, constipation, fever, decreased platelet count, fatigue, cough, headache, rash, injection site reactions and pain at the site of injection. If the side effects bother you, inform your doctor. A trained healthcare professional will administer Bizisa Injection 1's. Hence, do not self-administer.
Bizisa Injection 1's should be avoided if you are allergic to it or any other components present in it. Before receiving this injection, inform your doctor if you have any pre-existing or a history of liver/kidney disease, cardiac disorders, cancer, active infections, skin problems, or any allergic conditions. Bizisa Injection 1's is known to cause embryo-fetal toxicity. Hence, if you are pregnant or breastfeeding, inform your doctor beforehand.
Uses of Bizisa Injection 1's
Medicinal Benefits
Bizisa Injection 1's contains Bendamustine, which belongs to the class of alkylating agents. It works by inhibiting the DNA and RNA transcription that is essential for protein synthesis. This causes shrinkage of tumor cells and thereby prevents the growth and further spread of cancerous or non-cancerous cells. This medicine is used in the treatment of chronic lymphocytic leukemia and non-Hodgkin’s leukemia.
Directions for Use
Side Effects of Bizisa Injection 1's
Drug Warnings
Bizisa Injection 1's should be avoided if you are allergic to it or any other components present in it. Let your doctor know about your complete medical history, including current medication, to rule out any side effects/interactions. Before receiving this injection, inform your doctor if you have any history of liver/kidney disease, cardiac disorders, cancer, active infections, skin problems, or any allergic conditions. Bizisa Injection 1's may cause myelosuppression, active infections, severe skin reactions, tumor lysis syndrome (tumor cells release their contents into the bloodstream), other malignancies, and hypersensitivity reactions in some patients. Hence, careful monitoring should be done during the entire treatment. Bizisa Injection 1's may cause embryo-fetal toxicity. Hence, if you are pregnant or planning to become pregnant, inform your doctor beforehand. Before nursing, a breastfeeding mother should ask her oncologist whether this medicine is safe for use or not. Bizisa Injection 1's is not recommended for use in children as the safety and efficacy are not established.
Drug-Drug Interactions
Drug-Food Interactions
Drug-Diseases Interactions
Drug-Drug Interactions Checker List
Habit Forming
Special Advise
Diet & Lifestyle Advise